{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P12804",
      "entity_text" : "prothrombinase",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Although both inhibitors reduced prothrombinase induced thrombin production in a concentration dependent manner (XREF_FIG), the K i value for rivaroxaban was 4-fold lower than that for apixaban (0.7 +/- 0.3 nM and 2.9 +/- 0.5 nM, respectively; p < 0.02).",
  "reading_complete" : "2020-08-02T12:32:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:30:02Z",
  "trigger" : "induced",
  "evidence" : [ "prothrombinase-induced thrombin" ],
  "pmc_id" : "6524873",
  "score" : 0
}